How Long Does It Take for Liver Enzymes to Go Down?

Discover the factors influencing how long it takes for elevated liver enzymes to return to normal levels and what you can do to support recovery.

Liver enzymes can drop back to normal in as little as a few days or take six months or longer, depending almost entirely on what caused them to rise in the first place. Alcohol-related elevations often improve within two weeks of abstinence, while fatty liver disease tied to excess weight may take three to six months of sustained lifestyle changes. Acute drug toxicity, bile duct blockages, herbal supplement injuries, and even strenuous exercise each follow their own distinct timelines. The cause is the clock.

After Stopping Alcohol

Alcohol is one of the most common reasons liver enzymes show up high on a blood test, and it is also one of the causes where improvement comes fastest. In a study of patients with alcohol dependence who stopped drinking, AST levels dropped from a mean of about 65 IU/L at baseline to roughly 32 IU/L by day 14. ALT followed a similar path, falling from around 54 to about 29 IU/L over the same two weeks. GGT, which is particularly sensitive to alcohol use, dropped from about 120 to 58 IU/L in that period. Those are dramatic reductions for just 14 days of abstinence.

GGT tends to be the slowest of the three to normalize completely, because it reflects longer-term changes in liver cell membranes rather than acute cell damage. If you have been drinking heavily for years, GGT may take a month or more to reach normal even though AST and ALT settle down sooner. Still, the overall message is encouraging: even two weeks of no alcohol produces measurable, meaningful improvement.

Worth noting: these timelines assume the liver has not already progressed to cirrhosis or advanced fibrosis. Once scar tissue replaces enough functioning liver, enzymes may stay elevated or behave unpredictably regardless of abstinence. If you stop drinking and your numbers barely budge after a month, that is worth a deeper conversation with your doctor about imaging or further evaluation.

Acetaminophen Overdose and Acute Toxicity

Acetaminophen (paracetamol) overdose represents the extreme end of how fast liver enzymes can spike and how quickly they can drop once the threat is removed. After an overdose, AST levels typically begin rising within 24 hours of ingestion. In one study of overdose patients, AST peaked within 72 hours in 95% of cases, with median peak values around 422 IU/L and some patients exceeding 8,000 IU/L.

Once the toxic metabolite is cleared and the liver begins repairing, enzymes fall at different rates. AST drops with a half-life of about 15 hours, meaning it halves roughly every 15 hours. ALT is slower, with a half-life closer to 40 hours. In practical terms, someone whose AST peaked at 1,000 IU/L after an acetaminophen overdose might see it below 100 within three or four days, assuming no ongoing liver failure. ALT lingers longer because it clears from the bloodstream more slowly, but even ALT usually normalizes within a week or two in uncomplicated cases.

This is specific to acetaminophen toxicity, where the insult is acute and finite. Other types of drug injury follow very different patterns.

Other Medications and Drug-Induced Liver Injury

Drug-induced liver injury, often called DILI, covers a wide range of medications: antibiotics, statins, anti-seizure drugs, certain chemotherapies, and dozens of others. Unlike acetaminophen overdose, where the timeline is compressed into hours and days, DILI from other medications often takes weeks or months to resolve after the offending drug is stopped.

Most studies define complete resolution as liver enzymes returning to normal within three to six months of stopping the medication. When the pattern of injury is primarily hepatocellular, meaning the liver cells themselves are damaged, enzymes that remain elevated beyond three months after drug withdrawal may signal chronic injury. When the damage pattern is cholestatic or mixed, meaning bile flow is disrupted along with some cell damage, a longer window of up to six months is used before labeling the injury as chronic.

Herbal supplements and botanical products deserve their own mention here, because they are a frequently overlooked cause of liver injury. A systematic review of herb-induced liver injury found that liver function normalized in a mean of about 77 days after stopping the product. That is roughly two and a half months. Green tea extract, kava, black cohosh, and various traditional Chinese herbal blends are among the more commonly reported culprits. The tricky part is that people often do not think to mention supplements when asked about medications, and clinicians may not ask. If your enzymes are elevated and you take any herbal products, stopping them and rechecking in two to three months is a reasonable step.

Fatty Liver Disease and Weight Loss

Non-alcoholic fatty liver disease is now the most common cause of mildly elevated liver enzymes in developed countries, and the timeline for improvement is tied directly to how much weight you lose and how consistently. In a study of obese adults with metabolic syndrome, 12 weeks of calorie restriction reduced ALT by about 20 to 24%, with no meaningful difference between diet alone and diet plus exercise. That improvement came alongside weight loss averaging roughly 8 to 9%.

A longer study found that people who stuck with their program and lost about 7% of body weight within three months saw improvements in ALT, AST, and GGT. By six months, with weight loss reaching around 10%, those improvements continued. People who were less adherent and lost only about 2% of their weight still saw some improvement in ALT and AST at three months, but the effect was smaller. The pattern is dose-dependent: more weight loss yields bigger and faster enzyme drops, but even modest loss helps.

Dietary patterns matter too. An umbrella review of natural products and dietary interventions found that high-protein diets, Mediterranean diets, and calorie-restriction diets were associated with reduced liver enzymes, while most individual supplements and herbs had minimal or no effect. In other words, overall eating patterns outperform pill-based approaches by a wide margin.

There is an important reason not to ignore elevated enzymes caused by fatty liver, even if you feel fine. Long-term follow-up data show that people with non-alcoholic fatty liver disease and elevated enzymes carry a meaningful risk of eventually developing end-stage liver disease. Enzymes staying elevated is not just a lab curiosity; it reflects ongoing liver stress that, over years, can progress to fibrosis and cirrhosis.

Biliary Obstruction

When a gallstone or tumor blocks the bile duct, a different set of enzymes rises most prominently: alkaline phosphatase (ALP) and GGT, along with bilirubin. These can spike dramatically while AST and ALT remain only mildly elevated. Once the blockage is relieved, either by removing the stone endoscopically or through surgery, the timeline for normalization depends on how long the obstruction lasted and how complete the procedure was.

After therapeutic endoscopic procedures to clear a blocked common bile duct, alkaline phosphatase dropped at a rate of about 7 IU/L per day, while total bilirubin fell by roughly 0.6 mg/dL per day. In a study tracking patients after gallbladder removal for gallstone disease, both ALP and GGT fell substantially by postoperative day 7 and continued declining. Full normalization after elective gallbladder surgery typically took about three weeks in one study.

If enzymes do not drop as expected after a biliary procedure, it raises concern about an incomplete clearance, a retained stone, or a stricture that is still partially blocking bile flow. Surgeons and gastroenterologists typically recheck labs within a few weeks for exactly this reason.

When the Liver Is Not Actually the Problem

One of the more surprising reasons liver enzymes can be elevated has nothing to do with liver disease at all. Strenuous exercise, particularly intense resistance training or endurance events, causes muscle breakdown that releases AST and ALT into the bloodstream. These enzymes exist in muscle tissue too, not just in the liver, and a hard workout can push them well above normal ranges.

A study of healthy men found that AST, ALT, and several other markers rose significantly after heavy exercise and remained elevated for at least seven days afterward. A case report of a healthy adult male whose liver enzymes were flagged on routine blood work confirmed that simply resting from exercise for seven days was enough to bring all values back to normal. If you lift weights regularly or ran a marathon the week before your blood test, mildly elevated AST or ALT may mean nothing more than sore muscles.

There is also the matter of normal test-to-test variability. Liver enzyme results fluctuate from one blood draw to the next even when nothing has changed. An analysis of adults who had mildly elevated liver enzymes on an initial test found that more than 30% of those with elevated AST, ALT, or bilirubin would be reclassified as normal if simply retested. GGT was more stable, with only about 12% reclassified on repeat testing. This natural fluctuation is one reason most doctors will recheck an abnormal result before launching a full workup: a single mildly elevated reading may simply be noise.

Pregnancy-Related Elevations

Elevated liver enzymes during pregnancy are most commonly associated with preeclampsia and the related HELLP syndrome, where high blood pressure damages the liver. In most women, enzymes come down after delivery, but the timeline is not instant. Clinicians generally expect to confirm that liver values have returned to normal by the six-week postpartum visit. If they remain elevated at that point, further investigation is warranted, because persistent elevations after a pregnancy complicated by preeclampsia sometimes reveal an underlying condition like autoimmune hepatitis that was unmasked by the pregnancy.

GLP-1 Medications and Bariatric Surgery

Two of the more powerful tools now available for reducing liver enzymes in people with obesity and fatty liver disease are GLP-1 receptor agonist drugs like semaglutide and bariatric surgery. Both work largely by driving significant weight loss, but emerging data suggest the medications may have some direct anti-inflammatory effects on the liver as well.

A meta-analysis of semaglutide trials found that ALT dropped by a mean of about 14 U/L and AST by about 7 U/L compared to baseline. In weight management trials, roughly a quarter to nearly half of subjects with elevated baseline ALT saw their levels return to normal, compared to about 18% on placebo. These improvements emerged over the treatment periods of the trials, typically 6 to 12 months.

Bariatric surgery produces even larger and more durable changes. In patients whose ALT was elevated before surgery, levels dropped significantly by four months after the procedure and remained lower throughout five years of follow-up. A large Swedish study tracking obese patients found that both ALT and AST were reduced in the surgery group at two years, and the ALT reduction persisted at ten years. There may be differences between surgical types: sleeve gastrectomy showed statistically significant improvement in a direct measure of liver function at one year, while gastric bypass showed improvement that did not reach significance in one comparison. Both procedures still outperformed no intervention.

When Enzymes Refuse to Normalize

Sometimes you do everything right, or at least everything identifiable is addressed, and AST remains stubbornly elevated. Before assuming the worst, it is worth knowing about a benign laboratory phenomenon called macro-AST. This occurs when AST molecules in the blood clump together or bind to other proteins, forming complexes that are too large for the kidneys to filter out efficiently. The result is a persistently elevated AST reading that does not reflect any ongoing liver damage.

Macro-AST is not rare enough to ignore. It has been documented in patients with fatty liver disease, where it can create confusion by making the AST elevation look disproportionate to the degree of actual liver injury. Clues that point toward macro-AST include an AST that is persistently high while ALT is normal or only mildly elevated, and the absence of any other explanation despite a thorough workup. A simple lab test using a precipitation method can confirm it, but many clinicians do not think to order it, leading some patients through unnecessary biopsies and imaging. If your AST has been elevated for months with no clear cause and everything else looks fine, asking about macro-AST is reasonable.

Beyond laboratory artifacts, genuinely persistent elevations after the underlying cause has been addressed can signal that the liver has already sustained structural damage: fibrosis or early cirrhosis. At that point, enzymes may fluctuate but rarely settle back to normal, because the architecture of the organ itself has changed. This is one reason monitoring the trend over time matters more than fixating on any single lab draw.